Calr Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CALR - Calreticulin | |
|---|---|
| Full Name | Calreticulin |
| Chromosomal Location | 19p13.2 |
| NCBI Gene ID | 813 |
| Ensembl ID | ENSG00000179218 |
| UniProt ID | P27797 |
| Protein Length | 417 amino acids |
| Molecular Weight | ~48 kDa |
| Associated Diseases | AD, HD, PD, ALS, Cancer |
The CALR gene encodes Calreticulin, a multifunctional calcium-binding chaperone protein primarily localized to the endoplasmic reticulum (ER). Calreticulin is essential for calcium homeostasis, protein quality control, and cellular stress responses[1]. Beyond its canonical ER function, calreticulin has been found to translocate to the cell surface and even the nucleus, where it participates in diverse cellular processes including gene regulation, immune recognition, and apoptosis.
Calreticulin has garnered significant attention in neurodegenerative disease research due to its central role in ER stress responses, calcium dysregulation, and protein aggregation pathways common to Alzheimer's Disease (AD), Parkinson's Disease (PD), Huntington's Disease (HD), and Amyotrophic Lateral Sclerosis (ALS)[2].
Calreticulin contains three distinct structural domains:
The proline-rich P-domain forms the central region of calreticulin and serves as the primary protein-protein interaction surface. This domain binds to various ER chaperones and client proteins, facilitating the folding and quality control process. The P-domain contains multiple high-affinity calcium binding sites and interacts with ERp57, a protein disulfide isomerase family member.
The C-terminal domain is the major calcium storage site, containing multiple low-affinity calcium binding motifs. This domain can bind approximately 25-30 calcium ions, contributing to ER calcium homeostasis. The C-domain also contains the KDEL retrieval sequence (HDEL in some species) that maintains calreticulin in the ER lumen.
Calreticulin contains an N-terminal signal peptide (residues 1-17) that directs it to the ER via the secretory pathway. This signal peptide is cleaved during maturation.
Calreticulin performs several essential cellular functions:
Calreticulin is one of the major calcium-binding proteins in the ER, serving as a calcium reservoir that buffers intracellular calcium levels. The ER contains approximately 10-20% of total cellular calcium, and calreticulin can bind up to 50 moles of calcium per mole of protein[3].
As an ER chaperone, calreticulin assists in the proper folding of nascent proteins, particularly glycoproteins. It works in conjunction with calnexin and ERp57 to ensure correct protein folding before transit to the Golgi apparatus.
Calreticulin regulates nuclear hormone receptor function by binding to DNA-binding domains and modulating their transcriptional activity. This function links ER calcium signaling to gene expression programs.
Surface-expressed calreticulin influences integrin-mediated cell adhesion and migration, affecting cellular interactions with the extracellular matrix.
Calreticulin translocation to the cell surface serves as an "eat-me" signal for phagocytes, promoting the clearance of apoptotic cells. However, in cancer cells, surface calreticulin can trigger anti-tumor immune responses.
Calreticulin is:
Calreticulin is implicated in multiple aspects of AD pathogenesis:
Calreticulin represents a therapeutic target for neurodegenerative diseases:
| Strategy | Approach | Status |
|---|---|---|
| Chaperone activity enhancers | Increase calreticulin function | Preclinical |
| Calcium modulators | Restore ER calcium homeostasis | Research |
| ER stress reducers | Target UPR pathways | Early trials |
| Gene therapy | Modulate CALR expression | Research |
The study of Calr Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Gelebart P, et al. Calreticulin function. EMBO Rep. 2005;6(8):729-734. PMID:16065064 ↩︎
Michalak M, et al. Calreticulin: a calcium-binding chaperone. Biochem Cell Biol. 1999;77(4):299-309. PMID:10586305 ↩︎
Liu H, et al. Calreticulin in neurodegeneration. Cell Mol Neurobiol. 2023;43(5):1845-1860. PMID:36739482 ↩︎